Skip to content

XIV International HIV Drug Resistance Workshop: Entry inhibitors

Key take-home messages from the XIV International HIV Drug Resistance Workshop

XIV International HIV Drug Resistance Workshop: Clinical response

XIV International HIV Drug Resistance Workshop: Subtypes, resistance pathways and implications for therapy

XIV International HIV Drug Resistance Workshop: preventing mother-to-child transmission

Sexual transmission of HCV found in Swiss HIV-positive gay men

IAVI and GSK join forces in vaccine development

Two generic versions of nevirapine approved for PEPFAR use

Duration of ddI treatment and dose risk factors for CD4 loss in patients taking ddI/tenofovir